National Health Investors (NYSE:NHI) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a research report report published on Saturday, Zacks.com reports.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Separately, ValuEngine upgraded National Health Investors from a sell rating to a hold rating in a research note on Friday, October 25th. Three analysts have rated the stock with a sell rating and two have issued a hold rating to the company. The stock presently has a consensus rating of Sell and a consensus target price of $79.50.

NHI stock traded down $1.25 during mid-day trading on Friday, reaching $79.27. The company had a trading volume of 290,253 shares, compared to its average volume of 201,569. The company has a quick ratio of 14.42, a current ratio of 14.42 and a debt-to-equity ratio of 1.04. The stock has a market capitalization of $3.58 billion, a P/E ratio of 14.47, a P/E/G ratio of 3.76 and a beta of 0.27. National Health Investors has a one year low of $73.35 and a one year high of $86.54. The stock’s 50-day simple moving average is $83.50 and its two-hundred day simple moving average is $80.59.

National Health Investors (NYSE:NHI) last posted its earnings results on Thursday, November 7th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.42). The company had revenue of $81.68 million during the quarter, compared to the consensus estimate of $79.96 million. National Health Investors had a net margin of 50.71% and a return on equity of 11.00%. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.39 earnings per share. On average, research analysts forecast that National Health Investors will post 5.49 EPS for the current fiscal year.

In other National Health Investors news, Director James R. Jobe sold 900 shares of the firm’s stock in a transaction on Tuesday, September 24th. The stock was sold at an average price of $83.23, for a total value of $74,907.00. Following the sale, the director now directly owns 12,052 shares in the company, valued at $1,003,087.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 5.11% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the business. GW&K Investment Management LLC increased its holdings in shares of National Health Investors by 8.7% during the third quarter. GW&K Investment Management LLC now owns 345,326 shares of the real estate investment trust’s stock valued at $28,451,000 after purchasing an additional 27,568 shares during the period. First Trust Advisors LP increased its holdings in shares of National Health Investors by 8.1% during the third quarter. First Trust Advisors LP now owns 64,227 shares of the real estate investment trust’s stock valued at $5,292,000 after purchasing an additional 4,833 shares during the period. Daiwa Securities Group Inc. increased its holdings in shares of National Health Investors by 51.4% during the third quarter. Daiwa Securities Group Inc. now owns 10,900 shares of the real estate investment trust’s stock valued at $898,000 after purchasing an additional 3,700 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of National Health Investors by 18.3% during the third quarter. Russell Investments Group Ltd. now owns 20,686 shares of the real estate investment trust’s stock valued at $1,704,000 after purchasing an additional 3,193 shares during the period. Finally, California Public Employees Retirement System increased its holdings in shares of National Health Investors by 32.0% during the third quarter. California Public Employees Retirement System now owns 96,892 shares of the real estate investment trust’s stock valued at $7,983,000 after purchasing an additional 23,504 shares during the period. Institutional investors own 69.62% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: What are the components of an earnings report?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *